ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis

PHASE2CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Actinic Keratosis

Interventions

DRUG

ACT01

DRUG

Comp01

DRUG

Comp02

DRUG

Comp03

DRUG

Comp04

Trial Locations (4)

Dermatology Consulting Services; Zoe Diana Draelos, MD, High Point

Tennessee Clinical Research Center, Nashville

Dermatology Specialists Research, LLC, Louisville

Therapeutics Clinical Research, San Diego

All Listed Sponsors

lead

Promius Pharma, LLC

INDUSTRY

NCT02126670 - ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis | Biotech Hunter | Biotech Hunter